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Oral Mucosal Epithelial Cells Grown 
on Porous Silicon Membrane for 
Transfer to the Rat Eye
Yazad D. Irani  1, Sonja Klebe2, Steven J. P. McInnes3, Marek Jasieniak3, Nicolas H. 
Voelcker3,4,5 & Keryn A. Williams1
Dysfunction of limbal stem cells or their niche can result in painful, potentially sight-threatening ocular 
surface disease. We examined the utility of surface-modified porous-silicon (pSi) membranes as a 
scaffold for the transfer of oral mucosal cells to the eye. Male-origin rat oral mucosal epithelial cells were 
grown on pSi coated with collagen-IV and vitronectin, and characterised by immunocytochemistry. 
Scaffolds bearing cells were implanted into normal female rats, close to the limbus, for 8 weeks. 
Histology, immunohistochemistry and a multiplex nested PCR for sry were performed to detect 
transplanted cells. Oral mucosal epithelial cells expanded on pSi scaffolds expressed the corneal 
epithelial cell marker CK3/12. A large percentage of cells were p63+, indicative of proliferative 
potential, and a small proportion expressed ABCG2+, a putative stem cell marker. Cell-bearing 
scaffolds transferred to the eyes of live rats, were well tolerated, as assessed by endpoint histology. 
Immunohistochemistry for pan-cytokeratins demonstrated that transplanted epithelial cells were 
retained on the pSi membranes at 8 weeks post-implant, but were not detectable on the central cornea 
using PCR for sry. The pSi scaffolds supported and retained transplanted rat oral mucosal epithelial cells 
in vitro and in vivo and recapitulate some aspects of an artificial stem cell niche.
The mammalian cornea is covered by specialised, non-keratinised epithelial cells that regenerate throughout life 
from adult stem cells located primarily at the limbus. Limbal stem cell deficiency, reflecting the loss or dysfunc-
tion of these adult stem cells, or disruption of the niche in which they reside, can result in painful and potentially 
blinding disease characterised by conjunctivalisation of the ocular surface, corneal vascularisation, and edema1–7.
Unilateral limbal stem cell deficiency can be treated by limbal transplantation using autologous tissue from the 
unaffected eye8. Bilateral disease necessitates allogeneic limbal stem cell transplantation, in which either tissue or 
ex vivo-expanded cells sourced from cadaveric human donors is used9, 10. Allogeneic limbal grafts tend to undergo 
immunological rejection, even under concurrent immunosuppression11, 12. Oral mucosa (OM) is an attractive 
alternative source of autologous cells for corneal surface regeneration as it is non-keratinised13, harbours adult 
epithelial stem cells14, 15, and can be relatively easily harvested16.
Proof-of-principle reports that autologous oral mucosal epithelial cells could restore the ocular surface in 
experimental animal models17–19 were followed in 2004 by a landmark report describing successful transfer of 
cell sheets, expanded from autologous buccal mucosa on amniotic membrane, to repair the damaged ocular 
surface in four human patients20. Oral mucosal epithelial cells obtained from biopsies and expanded on various 
scaffolds have since been transplanted as “bandages” to treat human ocular surface disease21, 22. However, the use 
of autologous oral mucosal epithelial cells to repopulate a stem cell niche has thus far received little attention. 
Reconstruction of such a niche requires not only a source of cells, but also an implantable scaffold to support the 
transplanted cells.
Porous silicon (pSi)23 exhibits some potential as a scaffold in regenerative medicine24–28. Psi membranes are 
inorganic, allowing efficient sterilization29, are biocompatible in vitro25, 30–32 and in vivo30, 33, degrade to non-toxic 
silicic acid34, can be surface-modified to improve degradation35–37 and attachment of cells38, 39, and can be loaded 
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with proteins and growth factors40. We have previously shown that human corneal epithelial cells can be grown 
on pSi membranes coated with rat tail collagen, and that aminosilanised pSi membranes implanted under the rat 
conjunctiva do not erode the surrounding tissue41.
Herein, we describe the characterisation of rat oral mucosal epithelial cells grown on pSi membranes coated 
with collagen-IV and vitronectin, and the subsequent transplantation of the scaffolds into eyes of rats, in an 
attempt to recapitulate a limbal stem cell niche.
Results
Characterisation of pSi Membranes by SEM and ToF-SIMS. Scanning electron microscopy (SEM) 
of the oxidised pSi membranes revealed a thickness of 276 µm (Fig. 1a) and an average pore size of 21.2 ± 6.7 nm 
(Fig. 1b). The pores extended from the surface through the entire thickness of the membrane (Fig. 1c). To confirm 
successful functionalisation with aminosilane (APTES), normalised intensities of the CH2NH2+ fragment ion 
Figure 1. Characterization of pSi membrane materials. (a–c) Scanning electron micrographs of typical 
pSi membrane: (a) cross-sectional thickness, scale bar 100 µm; (b) surface pore structure en face, scale bar 
1 µm; (c) pore structure extending through membrane, scale bar 1 µm. (d,e) Time-of-flight secondary ion 
mass spectrometry: (d) Normalised intensity of the C2H2N+ fragment ion (amine) on pSi membrane and 
aminosilanised pSi membrane (pSi-NH2) surfaces; (e) Normalised intensity of the C9H8N+ immonium ion on 
aminosilanised pSi membrane (pSi-NH2) coated with collagen-IV (COL), vitronectin (VTN), and collagen-IV 
plus vitronectin (COL-IV/VTN), indicative of surface loading.
www.nature.com/scientificreports/
3ScIentIFIc REPORTS | 7: 10042  | DOI:10.1038/s41598-017-10793-1
on pSi membrane and its aminosilanised derivative pSi-NH2 were assessed by mass spectrometry (ToF-SIMS) 
(Fig. 1d). A narrow 95% confidence interval for the pSi-NH2 specimen indicated a homogeneous distribution 
of amine functional groups on the surface. To confirm surface adsorption of collagen-IV and vitronectin to 
pSi-NH2, ToF-SIMS was used to detect the C9H8N+ immonium ion on coated surfaces (Fig. 1e). Principal compo-
nent analysis (PCA) applied to positive mass spectra allowed discrimination between collagen-IV and vitronectin 
adsorption (Supplementary Fig. S1).
Characterisation of Rat Oral Mucosal Epithelial Cells. Epithelial cells harvested from the rat oral cav-
ity were first plated on collagen-IV-coated glass coverslips, to establish their proliferative capacity. Over 7 days, 
the cells proliferated to form colonies with the cobblestone appearance characteristic of epithelial cells. Centrally, 
colonies contained densely packed cuboidal cells, whereas cells on the colony borders were more flattened. To 
examine the ability of pSi membranes to support the growth of oral mucosal epithelial cells, freshly isolated cells 
were stained with the cell tracker dye PKH26, plated on collagen-IV-coated pSi membranes and examined at 24 h, 
48 h and 7 days. Cells survived, proliferated and formed colonies on the pSi scaffold (Supplementary Fig. S2).
To investigate the influence of different pSi membrane surface coatings on cell growth and phenotype, oral 
mucosal epithelial cells were plated on scaffolds coated with collagen-IV alone (pSi-NH2 + COL-IV), vitronectin 
alone (pSi-NH2 + VTN), or collagen-IV plus vitronectin (pSi-NH2 + COL-IV/VTN) and cultured for 7 days. 
Immunocytochemistry for corneal epithelial and putative stem cell markers was then performed (Fig. 2 and 
Table 1). Expression of CK3/12, a corneal epithelial differentiation marker, was variable but was most strongly 
expressed by cells grown on NH2 + COL-IV. Weak expression of CK19, a basal epithelial cell marker, was 
observed on cells grown on all coatings. Strong nuclear expression of the nuclear transcription factor p63, which 
labels transient amplifying cells, was observed in cells grown on all coatings. A small proportion of cells expressed 
the putative stem cell marker ABCG2. Because more cells expressed ABCG2 on pSi-NH2 + COL-IV/VTN than 
on those coated with either extracellular matrix protein alone (Table 1), all further experiments were performed 
with pSi-NH2 + COL-IV/VTN membranes.
Stability and Biocompatibility of Coated pSi Membranes in vivo. pSi-NH2 + COL-IV/VTN mem-
branes (without cells) were implanted into the subconjunctival space near the limbus of two female rats and 
followed for 8 weeks. The pSi membrane was clearly visible post-implantation (Fig. 3a). The implants caused 
mild erythema for up to two weeks, and new vessels grew in the vicinity of the implant (Fig. 3b). By four weeks 
post-implant, no residual inflammation was apparent. The pSi membrane underwent some degradation, as evi-
denced by the change in colour from black to brown (Fig. 3c). However, the implant remained visible at the 
operating microscope up to 8 weeks post-implantation (Fig. 3d). The new vessels around the site of the implant 
underwent remodelling with some regression (Fig. 3d). Endpoint histology confirmed the pSi membranes were 
still present at 8 weeks post-implant (Fig. 3e). Some inflammatory cells, indicative of a foreign body giant cell 
response, were observed at the implant site. There was no evidence of a fibrous capsule surrounding the mem-
brane, although some blood vessels were observed in the vicinity (Fig. 3f).
Transplantation of Oral Mucosal Cells on pSi Membranes to The Rat Eye. pSi-NH2 + COL-IV/
VTN membranes carrying 7 day cultured oral mucosal cells were implanted at the limbus of rats and followed for 
8 weeks. Endstage immunohistochemistry for cytokeratins was then performed, to detect transplanted epithelial 
cells remaining on the scaffolds. Weak expression of both pan-cytokeratin and cytokeratin 14, a basal epithelial 
marker, was observed in cells at the edge of the pSi implant (Fig. 4a,b,d,e), suggesting that transplanted cells had 
survived on the implant and migrated locally. No cytokeratin expression was observed on control coated pSi 
membranes implanted without oral mucosal epithelial cells (Fig. 4c,f). The cells surrounding the implant did not 
express the transient amplifying cell marker p63 (Supplementary Fig. S3). We then performed labelling for the 
histiocyte marker CD163 to determine if the cells surrounding the implant consisted of epitheliod inflammatory 
cells. Sparse labelling for CD163 was observed (Supplementary Fig. S4) indicating the majority of cells were not 
histiocytes. Isotype matched antibodies were used as negative controls (Supplementary Fig. S5).
Migration of the transplanted cells across the corneal surface was assessed by impression cytology from the 
central cornea using FTA paper, followed by amplification of the male specific marker sry by PCR. As male cells 
were transplanted into female rats, amplification of the male specific gene sry allowed detection of the trans-
planted cells. The sensitivity of this assay allowed detection of a single male cell in the presence of female cells. 
A band corresponding to the expected size for arbp, a housekeeper gene, was detected in 17/24 (70%) samples 
tested, indicating that the FTA paper retrieved cells from the corneal surface and preserved amplifiable DNA 
from the majority of samples. That the male specific gene sry failed to amplify in any test sample (Fig. 5) indicated 
that no implanted donor cells were present on the central corneal surface. These data suggested that the rat oral 
mucosal epithelial cells supported on pSi scaffolds and transplanted to the limbus had not migrated to the central 
cornea.
Discussion
The transfer of a population of epithelial progenitor cells to the surface of the cornea as a living bandage, whether 
or not supported on a scaffold such as amniotic membrane, will not necessarily lead to long-term repair of a 
damaged ocular surface if the limbal stem cell niche has been irreparably damaged. Regeneration of such a niche 
requires first, a biocompatible scaffold that can be implanted surgically into the eye so that the integrity of the 
surrounding tissue is not compromised; second, incorporation of factors within the artificial niche that can retain 
and support the “stemness” of at least a proportion of the cells seeded within it, and third, a source of cells with 
capacity for self-renewal, proliferation and differentiation, to populate the artificial niche.
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We considered that small pieces of pSi membrane might have potential for the construction of an artificial 
niche because of their ease of fabrication from inorganic silicon, biocompatibility within the eye, capacity for 
surface modification, and ability to support mammalian cell attachment and growth40–43. The porous structure 
mimics to some extent the retes of the palisades of Vogt, and lends the material a large surface area into which 
bioactive factors can be loaded. The opacity of a pSi membrane yields some protection from incident light and 
is not a disadvantage, given that the material is to be implanted at the limbus, well away from the visual axis. A 
disadvantage might be the relative stiffness of the material.
Oral mucosa has already proved to be a valuable source of autologous epithelial stem cells for ocular bandages 
in human patients, for purposes of ocular surface repair and relief of pain14, 44, 45, and was the source of stem cells 
in this study. For development of a suitable experimental model in which to test the performance of an artificial 
Figure 2. Phenotype of rat oral mucosal epithelial cells in vitro. Immunocytochemistry for CK3/12, CK19, 
p63 and ABCG2 on cells grown on pSi membranes coated with collagen IV (pSi-NH2 + COL-IV), vitronectin 
(pSi-NH2 + VTN), or collagen IV plus vitronectin (pSi-NH2 + COL-IV/VTN) at 7 days after seeding. Inserts, 
isotype-matched negative control antibodies (X63 for CK3/12 and CK19; Sal5 for p63 and ABCG2). Nuclei 
stained with Hoechst 33342 dye (blue), actin filaments stained with Alexa Fluor 594 phalloidin (red). Scale bars 
50 µm.
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pSi membrane 
coating
Expression in cultured oral mucosal 
epithelial cells of: ce cells
CK 3/12 CK 19 p63 ABCG2
Collagen-IV −/ +  + +  + weak  +  +  + −/+
Vitronectin −/++  + weak  +  + + −/+
Collagen-
IV + vitronectin −/ + +  + weak  +  +  + −/++
Table 1. Summary of cytokeratin (CK) profile and putative stem cell marker expression in rat oral mucosal 
epithelial cells grown for 7 days on coated pSi membranes in vitro. − No expression observed; + expressed in a 
few cells; + + expressed in a minority of cells; + ++ expressed in a majority of cells.
Figure 3. Collagen-IV plus vitronectin coated pSi membranes (pSi-NH2 + COL-IV/VTN) were implanted 
under the conjunctiva of Sprague-Dawley rats. (a) pSi membrane (black arrow) visible at one day after 
implantation (white arrow marks the sutures). (b) Two weeks post implantation, mild inflammation and 
neovascularisation were apparent. (c) Four weeks post implantation, signs of degradation were apparent 
(scaffold colour changed from black to brown). (d) Eight weeks after implantation, the pSi membrane was still 
visible. An ophthalmic spear (asterisk) is visible at the top of images (a–d). The outline of the pSi membrane 
is traced with a red line in images (c,d). Images captured at the operating microscope. (e) Endpoint histology. 
Haematoxylin and eosin stained section of a rat eye showing the pSi membrane at 8 weeks post-implantation. 
Inflammatory cells are visible around the implant. Scale bar 100 µm. (f) Higher magnification of the area 
depicted by the box in image E. Some blood vessels (small black arrows) are seen in the vicinity of the implant. 
Scale bar 100 µm.
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Figure 4. Immunohistochemistry for cytokeratins to detect transplanted epithelial cells on coated pSi 
membranes at 8 weeks post-implant. (a) Cells weakly positive for pan-cytokeratin (white arrows) on the surface 
of the implant (asterisk). Strong expression of pan-cytokeratin is normally present in conjunctival epithelium 
(black arrow), serving as an internal positive control. (b) Higher magnification showing labelled cells on the 
surface of the implant. (c) pSi membranes without cells were implanted under the conjunctiva of rats for 8 
weeks. The cells in contact with the pSi (black arrows) did not express pan-cytokeratin, indicating they were not 
epithelial cells. (d) Cells in the vicinity of the pSi implant demonstrated positive labelling for cytokeratin 14. (e) 
Higher magnification showing CK14 labelled cells. (f) Tissue surrounding pSi membranes implanted without 
oral mucosal cells, was not positive for CK14. Scale bars for panels a and d 100 µ, and panels b, c, e, f 10 µm.
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limbal stem cell niche, we chose the rat. The availability of inbred strains, such as the inbred Sprague-Dawley used 
in this study, allowed transfer of cells from donors to recipients as histocompatible isografts. Because immune 
rejection will not occur, the need for concomitant immunosuppression can be avoided. Rat oral mucosal cells 
have been isolated previously by others, and shown to be fit for purpose46. Furthermore, rat oral mucosal cells 
exhibit reasonable proliferative potential47.
In our hands, rat oral mucosal cells cultured ex vivo on pSi membranes consisted of a heterogeneous popula-
tion of cells in varying degrees of differentiation. CK3/12, which is expressed by human mature central corneal 
epithelial cells48 but not found in basal limbal epithelial cells49, was expressed strongly in some cells while others 
exhibited low or no expression. Rat oral mucosal cells expressed low levels of CK19, a marker present in basal 
epithelial cells of the human peripheral cornea but not in the central cornea50. p63 is expressed in human kerat-
inocyte stem cells51. In human corneas, the transcription factor p63 localises to basal epithelial cells with higher 
expression at the limbus52, and is thought to label transient amplifying cells. A majority of rat oral mucosal cells 
exhibited strong nuclear expression of p63, indicating that the cells had most likely maintained their proliferative 
potential when cultured on pSi scaffolds. The most widely-used marker for putative corneal epithelial stem cells 
is the cell membrane-bound transporter protein, ABCG253–58. A small proportion of the cells expanded on pSi 
scaffolds expressed ABCG2, indicative of the presence of a small number of putative stem cells. In summary, the 
population of cultured rat oral mucosal cells contained some differentiated cells that expressed CK3/12, a large 
number of p63-positive transient amplifying cells, and a small number of stem cells that expressed ABCG2. We 
considered this mixture of cells to be appropriate for seeding an artificial stem cell niche.
The detailed proteome of the human limbal stem cell niche is still to be defined, however recent evidence sug-
gests that corneal epithelial stem cells carry the vitronectin receptor, αvβ5 integrin54, and that corneal, limbal and 
conjunctival basement membranes all contain collagen type IV is well-established55. Vitronectin and collagen-IV 
were thus used separately and in conjunction to coat pSi membranes designed to support oral mucosal cell attach-
ment and growth. Because more cells expressed ABCG2 on pSi-NH2 + COL-IV/VTN membranes than on those 
coated with either extracellular matrix protein alone, we selected the combination for further experimentation.
In deciding where to implant the artificial niche, we considered available literature. In the mouse, corneal 
oligopotent cells are widely distributed throughout the corneal epithelium56, but more recent data suggest that 
functionally, the limbus is the major repository for corneal epithelial stem cells57. Rather less is known about the 
corneal epithelial stem cell niche in the rat, but the available evidence would point to locations within the limbus 
or palpebral conjunctiva58, 59. We thus chose to implant pSi-NH2 + COL-IV/VTN membranes carrying cultured 
rat oral mucosal cells under the bulbar conjunctiva, as close as possible to the corneolimbal junction. Male donor 
cells were transferred to the eyes of female recipient rats to enable tracking of any migration of transplanted cells 
carrying sry: we have previously reported no influence of gender on limbal isograft survival in the rat11.
Although some oral mucosal cells remained on the implanted pSi membranes after 8 weeks, as evidenced by 
labelling for cytokeratins, we were unable to detect transplanted cells in the central cornea by sry PCR11, 60. Our 
assay was able to detect 8 pg of male genomic DNA, equivalent to 1 cell, in the presence of female cells. Under 
Figure 5. Failure to detect transplanted male oral mucosal epithelial cells on the central cornea of female rats. 
Male oral mucosal cells grown on coated pSi membrane scaffolds were implanted at the limbus of female rats. 
Cell samples were collected weekly from the cornea using FTA paper. The presence of transplanted male cells 
was detected by PCR for the male-specific sry gene. No male cells were detected on the surface of the corneas 
of the 3 female rats. L = 20 base pair ladder, W = water control, F = female rat genomic DNA, M = male rat 
genomic DNA, B = blank FTA disc, 1–8 = sample taken x weeks after transplantation.
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normal conditions, corneal epithelial cells migrate from the periphery to the centre of the cornea in 7 to 10 days61, 62. 
The length of the current study was 8 weeks, which might have provided sufficient time for the cells to migrate to 
the central cornea, especially as detection of transplanted cells on the scaffold at 8 weeks post-implant indicated 
their continuing presence. However, our corneas were normal, not wounded. Our findings point to the partial 
reconstruction of a niche capable of maintaining epithelial cells.
Materials and Methods
pSi Membranes. pSi was prepared as described previously63, except that current density of 166.7 mAcm−2 
was applied for 60 min. Membranes of pSi were separated from bulk silicon by electropolishing for 4 min in 1:20 
hydrofluoric acid: ethanol at 4 mAcm−2, oxidised in a tube furnace (LABEC, Marrickville, NSW, Australia) for 
1 hour at 600 °C, and aminosilanised with APTES as described previously41.
Scanning Electron Microscopy (SEM). SEM was performed with an ultra-high-resolution field emission 
gun MERLIN microscope with GEMINI II column (Carl Zeiss Microscopy GmbH, Jena, Germany) operating 
in high-resolution mode at accelerating voltage 2 kV. Secondary electron imaging was performed with a parallel 
on-axis in-lens secondary electron detector. The working distance was maintained at 2 mm.
Time-of-flight Secondary Ion Mass Spectrometry (ToF-SIMS). ToF-SIMS measurements were per-
formed with a PHI TRIFT V nanoTOF instrument (PHI Electronics Ltd, Chanhassen, MN, USA). A 30 keV, 
pulsed primary197Au+ ion beam was used to sputter and ionise species from each sample surface. Positive mass 
axis calibration was performed with CH3+, C2H5+ and C3H7+ whilst CH−, C2H− and F− were used to calibrate 
negative mass axis. Spectra were acquired under static SIMS conditions64. A mass resolution m/Δm of >7000 at 
nominal m/z = 27 amu (C2H3+) was typically achieved. Each sample was characterized by five positive ion mass 
spectra, collected from non-overlapping areas. Multiple mass spectra were processed by principal component 
analysis (PCA) and Analysis of Means65.
Coating of Porous Silicon Membranes. PSi membranes were coated with 10 µg human collagen-IV 
(Sigma-Aldrich, St. Louis, MO, USA), or 1 µg rat vitronectin (Sigma-Aldrich), or both collagen-IV and vitronec-
tin, as previously described42.
Experimental Animals. Inbred male and female Sprague-Dawley rats sourced from the Flinders University 
Animal Facility were exposed to a 12 hour light-dark cycle and allowed access to food and water ad libitum. All 
animal experiments were approved by the Animal Welfare Committee of Flinders University, and were in accord-
ance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the Australian 
Code of Practice for the Care and Use of Animals for Scientific Purposes.
Harvest and Culture of Rat Oral Mucosal Epithelial Cells. Oral mucosal epithelial tissue was har-
vested from 4–6 week old male rats. Tissue was washed with balanced salt-antibiotic solution (BSS, Alcon, Fort 
Worth, TX, USA; supplemented with 200 IU/ml penicillin, 200 µg/ml streptomycin and 10 ng/ml amphotericin; 
Life Technologies, Carlsbad, CA, USA) and placed in one ml MCDB153 medium (Sigma-Aldrich) with 2.2 U/
ml dispase I (Life Technologies) for 1 h at 37 °C. The epithelial tissue was gently detached from underlying tissue, 
washed in sterile BSS and placed in 500 µl 0.25% trypsin, 2.65 mM EDTA (Sigma-Aldrich) in BSS for 5 min. The 
tissue was gently disaggregated in one ml MCDB153 with 10% vol/vol fetal bovine serum (FBS), insulin trans-
ferrin sodium selenate supplement (Life Technologies), 100 U/ml penicillin/100 µg/ml streptomycin, 5 ng/ml 
amphotericin, 5 ng/ml epidermal growth factor (EGF) (Prospec Tany, Rehovot, Israel), 10 ng/ml β-nerve growth 
factor (NGF) (R&D Systems, Minneapolis, MN, USA), 200 ng/ml hydrocortisone (Sigma-Aldrich) and 0.03 pg/
ml tri-iodothyronine (Sigma-Aldrich) (“complete medium”). Cells were washed with 10 ml complete medium 
and pelleted at 100 g for 5 min, resuspended in complete medium, seeded on protein-coated aminosilanised pSi 
membranes in 24 well plates, and incubated at 37 °C with 5% CO2 in air. Cells were used at passage one. One-two 
donor rats were used per experiment. Cells were stained using the cell tracker dye PKH26 (Sigma-Aldrich) as 
described previously41.
Surgical Implantation of pSi Scaffolds into the Rat Eye. Protein-coated pSi membranes (1–2 
mm2), with or without cells attached, were implanted under the bulbar conjunctiva, at the limbus, of female 
Sprague-Dawley rats as described elsewhere41, 43.
Immunocytochemistry. Immunocytochemistry was performed on rat oral mucosal epithelial cells grown 
on pSi scaffolds as previously described41. Murine monoclonal antibodies with specificity for CK3/12 (clone AE5, 
IgG1, Millipore, Billerica, MA, USA), CK19 (clone E6,IgG1, Abcam, Cambridge, United Kingdom), p63 (clone 
4A4, IgG2a, Abcam), and ABCG2 (clone 5D3, IgG2b, Chemicon, Temecula, CA, USA) were used at a dilution of 
1/100 in phosphate-buffered saline with 1% vol/vol normal goat serum (Sigma-Aldrich). Negative controls were 
isotype-matched antibodies (X63: IgG1; Sal5: IgG2a) of irrelevant specificity. The secondary antibody was a goat 
anti-mouse IgG conjugated to Alexa Fluor 488 (Life Technologies). Cell nuclei were counterstained with 2 µg/
ml Hoechst 33342 (Sigma-Aldrich) for 5 min at room temperature. Where the protein of interest localised to the 
nucleus, cytoplasmic actin was stained with 1/200 Alexa Fluor 594 phalloidin (Life Technologies).
Endpoint Histology. Whole eyes were removed from rats 8 weeks post-pSi implantation, fixed in 10% buff-
ered formalin, embedded in paraffin wax, sectioned and stained with haematoxylin and eosin40. All sections were 
assessed by a qualified pathologist (SK).
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Immunohistochemistry. Formalin-fixed, paraffin-embedded tissue was sectioned at 6 µm thickness on a 
microtome (Leica, Wetzlar, Germany). Pan-cytokeratin antibody cocktail (Clones AE1/AE3) was sourced from 
Cell Marque (Rocklin, CA, USA). Cytokeratin 14 antibody was obtained from Abcam (clone RCK107, IgG1) and 
the CD163 antibody was purchased from Leica (clone 10D6, IgG1). Primary antibodies were diluted according to 
the manufacturer’s instructions. The Novolink polymer detection system (Leica, Wetzlar, Germany) was used to 
detect positive labelling according to the manufacturer’s instructions.
Impression Cytology and sry PCR. A 2 mm disc of FTA paper was applied to the central cornea, and 
gently agitated in a circular motion to collect superficial cells. The FTA discs were then placed in a sterile tube 
for later analysis by PCR. A two-step PCR protocol to amplify the male-specific sry gene was employed to detect 
transplanted cells. The first multiplexed step amplified the housekeeper gene arbp (to confirm presence of DNA 
in the samples) and the sry gene. The sensitivity of the detection system was enhanced using a second round of 
amplification using nested primers for sry. Each reaction consisted of 17.4 µl water, 2.5 µl 10X PCR buffer, 0.75 µl 
MgCl2, 0.25 µl dNTPs, 2 µl primer mix (20:1 ratio of ARBP and SRY1 primers, Table 2), and 0.1 µl Platinum Taq 
DNA polymerase (Life Technologies). Two µl of male rat genomic DNA was used as a positive control. FTA 
discs were added to the PCR mix and subjected to thirty cycles of denaturation at 95 °C, annealing at 62 °C and 
extension at 72 °C. The results of the PCR were visualised by separating 5 µl of the PCR product on a 2% agarose 
gel. Two microliters of the first PCR product (diluted 1/100) was used as the template in the second reaction. The 
PCR mix was prepared identically except that the primers SRY2 and SRY2rev were used (Table 2). An annealing 
temperature of 60 °C was used for the second reaction.
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